Notícias e actividades

Saúde - Gabinete da Ministra

Designação para a Inspeção-Geral das Atividades em Saúde.

JAMA - Association Between Administration of Systemic Corticosteroids and Mortality Among Critically Ill Patients With COVID-19 - A Meta-analysis

JAMA - Association Between Administration of Systemic Corticosteroids and Mortality Among Critically Ill Patients With COVID-19 - A Meta-analysis

JAMA NETWORK

Is administration of systemic corticosteroids associated with reduced 28-day mortality in critically ill patients with coronavirus disease 2019 (COVID-19)?

JAMA - Effect of Hydrocortisone on Mortality and Organ Support in Patients With Severe COVID-19 - The REMAP-CAP COVID-19 Corticosteroid Domain Randomized Clinical Trial

JAMA - Effect of Hydrocortisone on Mortality and Organ Support in Patients With Severe COVID-19 - The REMAP-CAP COVID-19 Corticosteroid Domain Randomized Clinical Trial

JAMA NETWORKDoes intravenous hydrocortisone, administered either as a 7-day fixed-dose course or restricted to when shock is clinically evident, improve 21-day organ support–free days (a composite end point of in-hospital mortality and the...
JAMA - Effect of Dexamethasone on Days Alive and Ventilator-Free in Patients With Moderate or Severe Acute Respiratory Distress Syndrome and COVID-19 The CoDEX Randomized Clinical Trial

JAMA - Effect of Dexamethasone on Days Alive and Ventilator-Free in Patients With Moderate or Severe Acute Respiratory Distress Syndrome and COVID-19 The CoDEX Randomized Clinical Trial

JAMA NETWORKIn patients with coronavirus disease 2019 (COVID-19) and moderate or severe acute respiratory distress syndrome (ARDS), does intravenous dexamethasone plus standard care compared with standard care alone increase the number of days...
JAMA - Effect of Hydrocortisone on 21-Day Mortality or Respiratory Support Among Critically Ill Patients With COVID-19 A Randomized Clinical Trial

JAMA - Effect of Hydrocortisone on 21-Day Mortality or Respiratory Support Among Critically Ill Patients With COVID-19 A Randomized Clinical Trial

JAMA NETWORK

Does low-dose hydrocortisone decrease treatment failure in patients with COVID-19–related acute respiratory failure?

NEJM - Phase 1–2 Trial of a SARS-CoV-2 Recombinant Spike Protein Nanoparticle Vaccine

NEJM - Phase 1–2 Trial of a SARS-CoV-2 Recombinant Spike Protein Nanoparticle Vaccine

The New England Journal of MedicineNVX-CoV2373 is a recombinant severe acute respiratory syndrome coronavirus 2 (rSARS-CoV-2) nanoparticle vaccine composed of trimeric full-length SARS-CoV-2 spike glycoproteins and Matrix-M1 adjuvant.
AMP - SARS-CoV-2 Pandemic: Should Children Wear Masks?

AMP - SARS-CoV-2 Pandemic: Should Children Wear Masks?

Acta Médica PortuguesaDuring the current SARS-CoV-2 pandemic, the World Health Organization has advised the use of masks, not only in healthcare facilities, but also in particular settings in the community where maintaining physical distance may...
Centro Hospitalar de Leiria, E. P. E.

Centro Hospitalar de Leiria, E. P. E.

Prestação de serviços médicos sem especialidade.

Trabalho, Solidariedade e Segurança Social - Caixa Geral de Aposentações, I. P.

Lista de aposentados e reformados a partir de 1 de outubro de 2020.

INFRAESTRUTURAS E HABITAÇÃO

Requisitos e procedimentos de reconhecimento das entidades prestadoras de serviços na área da medicina e na área da psicologia que pretendam realizar exames médicos e avaliações psicológicas a candidatos a maquinista e maquinistas de locomotivas...

Saúde - Gabinete do Secretário de Estado da Saúde

Serviços e estabelecimento de saúde que se consideram com maiores carências de pessoal médico nas áreas de saúde pública e hospitalar.
Primeiro234567911
Categorias

Categorias

Arquivo de Notícias

Arquivo